Genentech Gets FDA Priority Review For Rituxan in Children With Rare Blood Vessel Disorders

Date : 06/12/2019 @ 10:48AM
Source : Dow Jones News
Stock : Roche Holding (QX) (RHHBY)
Quote : 38.16  -0.28 (-0.73%) @ 8:59PM
After Hours
Last Trade
Last $ 38.16 ◊ 0.00 (0.00%)

Genentech Gets FDA Priority Review For Rituxan in Children With Rare Blood Vessel Disorders

Roche Holding (QX) (USOTC:RHHBY)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more Roche Holding (QX) Charts.

By Colin Kellaher


Roche Holding AG's (ROG.EB) Genentech unit Wednesday said the U.S. Food and Drug Administration accepted for priority review the company's supplemental biologics-license application for Rituxan in children with two rare blood vessel disorders.

Genentech said the sBLA covers the use of Rituxan, in combination with glucocorticoids, for the treatment of granulomatosis with polyangiitis and microscopic polyangiitis in children two years of age and older.

The FDA grants priority review to medicines that have the potential to provide significant improvements in the treatment of a serious disease, and the designation shortens the review period to six months from the standard 10 months.

The agency approved Rituxan in 2011 for the treatment of adults with two rare forms of vasculitis. Genentech said approval of the sBLA would mark the first pediatric indication for Rituxan.


Write to Colin Kellaher at


(END) Dow Jones Newswires

June 12, 2019 06:33 ET (10:33 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.